However, unlike any other treatments currently available, specific elimination of autoreactive B cells can also stop Graves’ Eye Disease and cardiomyopathy that are caused by cross-reactivity of anti-TSHR autoantibodies with the eyes and heart, while avoiding compromising the immune system. This evidence concerns the gene TSHR and cardiomyopathy.